PNC Financial Services Group’s Enzo Biochem, Inc. ENZ Stock Holding History

PNC Financial Services Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-700	Closed	-$259	–	5120
2025 Q1	$259	Hold	700	–	–	﹤0.01%	4744
2024 Q4	$500	Buy	+700	New	+$725	﹤0.01%	4529
2018 Q4	–	Sell	-183	Closed	-$1K	–	4200
2018 Q3	$1K	Sell	183 -1,817	-91%	-$8.25K	﹤0.01%	4068
2018 Q2	$10K	Buy	+2,000	New	+$12.2K	﹤0.01%	3694
2013 Q3	–	Sell	-249	Closed	-$1K	–	3667
2013 Q2	$1K	Buy	+249	New	+$550	﹤0.01%	3467

Other funds holding ENZ

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

PNC Financial Services Group's ENZ Position: Q2 2025 in Review

PNC Financial Services Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 700 shares — an estimated $259 sold.

PNC Financial Services Group first reported a position in ENZ in Q2 2013 and held it in 5 quarters. The position peaked at $10K in Q2 2018. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

PNC Financial Services Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
PNC Financial Services Group sold 700 Enzo Biochem, Inc. shares in Q2 2025, an estimated $259.
PNC Financial Services Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 5 quarters.
PNC Financial Services Group's Enzo Biochem, Inc. position peaked at $10K in Q2 2018.
6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.